Centessa Pharmaceuticals plc (CNTA)
USD 11.59
(2.84%)
USD 11.59
(2.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 6.85 Million | - | - | - | - |
| Cost of Revenue | 786.57 Thousand | 130.91 Thousand | 33.99 Thousand | - | - |
| Gross Profit | 6.06 Million | -130.91 Thousand | -33.99 Thousand | - | - |
| Operating Expenses | 178.13 Million | 210.28 Million | 139.28 Million | 10.44 Million | 5.05 Million |
| Selling, General and Administrative Expenses | 53.73 Million | 55.2 Million | 42.96 Million | 1.13 Million | 790 Thousand |
| Research and Development Expenses | 124.4 Million | 155.08 Million | 96.31 Million | 9.3 Million | 4.26 Million |
| Other Expenses | - | 2.34 Million | - | 155 Thousand | 105 Thousand |
| Cost and Expenses | 178.13 Million | 210.28 Million | 139.31 Million | 10.44 Million | 5.05 Million |
| Operating Income | -171.28 Million | -212.26 Million | -139.31 Million | -10.44 Million | -5.05 Million |
| Interest Expense | 9.9 Million | 7.03 Million | 2.54 Million | 378 Thousand | 118 Thousand |
| Income Tax Expense | -25.05 Million | -747 Thousand | 113.98 Thousand | 378 Thousand | 223 Thousand |
| Earnings before Tax | -176.14 Million | -216.95 Million | -381.74 Million | -10.66 Million | -5.06 Million |
| Net Income | -151.08 Million | -216.2 Million | -381.85 Million | -11.04 Million | -5.28 Million |
| Earnings Per Share Basic | -1.57 | -2.31 | -4.24 | -0.08 | -0.07 |
| Earnings Per Share Diluted | -1.57 | -2.31 | -4.24 | -0.08 | -0.07 |
| Weighted Average Shares Outstanding | 96.17 Million | 93.4 Million | 89.98 Million | 142.05 Million | 70.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 96.17 Million | 93.4 Million | 89.98 Million | 142.05 Million | 70.89 Million |
| Gross Margin | 0.89 | - | - | - | - |
| EBIT Margin | -24.23 | - | - | - | - |
| Profit Margin | -22.05 | - | - | - | - |
| EBITDA | -166.06 Million | -212.26 Million | -379.15 Million | -10.43 Million | -4.93 Million |
| Earnings Before Tax Margin | -24.99 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 6.91 Million | 6.87 Million | - | - |
| Cost of Revenue | 236.26 Thousand | 239.86 Thousand | 248.13 Thousand | 813.13 Thousand | 236.61 Thousand | 237.76 Thousand |
| Gross Profit | -236.26 Thousand | -239.86 Thousand | 6.66 Million | 6.06 Million | -236.61 Thousand | -237.76 Thousand |
| Operating Expenses | 43.79 Million | 35.82 Million | 42.14 Million | 178.01 Million | 40.2 Million | 47.01 Million |
| Selling, General and Administrative Expenses | 10.94 Million | 13.19 Million | 12.17 Million | - | 12.01 Million | 13.34 Million |
| Research and Development Expenses | 32.85 Million | 22.63 Million | 29.97 Million | - | 28.19 Million | 33.67 Million |
| Other Expenses | 154 Thousand | -1.53 Million | -878 Thousand | -5.42 Million | -1.67 Million | -1.52 Million |
| Cost and Expenses | 44.02 Million | 36.06 Million | 42.39 Million | 178.82 Million | 40.2 Million | 47.01 Million |
| Operating Income | -44.02 Million | -36.06 Million | -35.48 Million | -171.94 Million | -40.2 Million | -47.01 Million |
| Interest Expense | 2.52 Million | 2.52 Million | 2.57 Million | 9.9 Million | 2.54 Million | 2.45 Million |
| Income Tax Expense | 705.79 Thousand | 480.72 Thousand | 1.15 Million | -25.15 Million | -2.82 Million | -24.05 Million |
| Earnings before Tax | -43.15 Million | -37.54 Million | -36 Million | -176.82 Million | -41.47 Million | -48.93 Million |
| Net Income | -43.86 Million | -38.02 Million | -37.15 Million | -151.67 Million | -38.64 Million | -24.88 Million |
| Earnings Per Share Basic | -0.40 | -0.38 | -0.38 | - | -0.40 | -0.26 |
| Earnings Per Share Diluted | -0.40 | -0.38 | -0.38 | - | -0.40 | -0.26 |
| Weighted Average Shares Outstanding | 109.48 Million | 99.88 Million | 97.92 Million | 96.17 Million | 96.64 Million | 95.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 109.48 Million | 99.88 Million | 97.92 Million | 96.17 Million | 96.64 Million | 95.16 Million |
| Gross Margin | - | - | 0.96 | 0.88 | - | - |
| EBIT Margin | - | - | -5.10 | - | - | - |
| Profit Margin | - | - | -5.38 | -22.05 | - | - |
| EBITDA | -43.79 Million | -35.82 Million | -35.23 Million | - | -38.69 Million | -46.25 Million |
| Earnings Before Tax Margin | - | - | -5.13 | -24.99 | - | - |
TENB
MRDH
NHOLF
BTOG
0J8Z
BP-B